Sigma Planning Corp Agenus Inc Transaction History

Sigma Planning Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$1.96 - $3.14 $1,421 - $2,276	-725 Reduced 5.65%	12,100 $25,000
Q2 2022 Aug 11, 2022	SELL	$1.3 - $2.64 $1,267 - $2,574	-975 Reduced 7.07%	12,825 $25,000
Q4 2021 Feb 02, 2022	SELL	$2.92 - $5.74 $5,840 - $11,480	-2,000 Reduced 12.66%	13,800 $44,000
Q3 2021 Oct 28, 2021	BUY	$4.98 - $6.63 $78,684 - $104,754	15,800 New	15,800 $83,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Sigma Planning Corp with notifications on news.